Papers - TANABE JUTARO
-
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
Murakami H, Tanabe J, Tamasawa N, Matsumura K, Yamashita M, Matsuki K, Murakami H, Matsui J, Suda T
Diabetes research and clinical practice 99 ( 1 ) 30 - 8 2013.1
-
Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 mutation.
Tamasawa N, Takayasu S, Murakami H, Yamashita M, Matsuki K, Tanabe J, Murakami H, Matsui J, Satoh K, Suda T
Journal of clinical lipidology 6 ( 1 ) 74 - 80 2012.1
-
Therapeutic Intervention Through PPARs in Glucose and Lipid Homeostasis Involving Obesity : Clinical Significance of PPARα・γ Dual Agonists
TAMASAWA N., TANABE J., MATSUI J., SUDA T.
Journal of the Japan Diabetes Society 54 ( 3 ) 161 - 164 2011.3
-
Therapeutic Intervention Through PPARs in Glucose and Lipid Homeostasis Involving Obesity: Clinical Significance of PPAR<i>α</i>·<i>γ</i> Dual Agonists
Tamasawa N., Tanabe J., Matsui J., Suda T.
Journal of the Japan Diabetes Society 54 ( 3 ) 161 - 164 2011
-
The Frequency of Type 2 Diabetic Patients who Meet the Endocrinological Screening Criteria of Subclinical Cushing's Disease
MURAKAMI HIROSHI, NIGAWARA TAKESHI, SAKIHARA SATORU, KAGEYAMA KAZUNORI, YAMASHITA MAKI, MATSUKI KOTA, TANABE JUTARO, MATSUI JUN, TAMASAWA NAOKI, SUDA TOSHIHIRO
Endocrine journal 57 ( 3 ) 267 - 272 2010.3
-
Insulin Suppresses HDL-Mediated Cholesterol Efflux from Macrophages Through Inhibition of Neutral Cholesteryl Ester Hydrolase and ATP-Binding Cassette Transporter G1 Expressions
Yamashita Maki, Tamasawa Naoki, Matsuki Kota, Tanabe Jutaro, Murakami Hiroshi, Matsui Jun, Suda Toshihiro
Ｊｏｕｒｎａｌ ｏｆ Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ ａｎｄ Ｔｈｒｏｍｂｏｓｉｓ 17 ( 11 ) 1183 - 1189 2010
-
Metformin restores impaired HDL-mediated cholesterol efflux due to glycation.
Matsuki K, Tamasawa N, Yamashita M, Tanabe J, Murakami H, Matsui J, Imaizumi T, Satoh K, Suda T
Atherosclerosis 206 ( 2 ) 434 - 8 2009.10
-
Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
Sugimoto K, Rashid IB, Kojima K, Shoji M, Tanabe J, Tamasawa N, Suda T, Yasujima M
Diabetes/metabolism research and reviews 24 ( 8 ) 642 - 50 2008.11
-
A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins.
Kageyama K, Sakihara S, Yamashita M, Takahashi K, Kawashima S, Tanabe J, Tsutaya S, Yasujima M, Suda T
The American journal of the medical sciences 335 ( 5 ) 398 - 402 2008.5
-
HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia
GUAN Jing-Zhi, TAMASAWA Naoki, MURAKAMI Hiroshi, MATSUI Jun, TANABE Jutaro, MATSUKI Kota, YAMASHITA Maki, SUDA Toshihiro
Journal of atherosclerosis and thrombosis 15 ( 1 ) 20 - 25 2008.2
-
アンギオテンシノーゲン遺伝子235T alleleを有する2型糖尿病腎症患者におけるACE阻害剤とARB併用によるアルブミン尿改善効果
松井 淳, 小川 吉司, 玉澤 直樹, 山下 真紀, 松木 恒太, 田辺 壽太郎, 村上 宏, 須田 俊宏
弘前医学 59 ( 2 ) 59 - 64 2008
-
HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia
Guan Jing-Zhi, Tamasawa Naoki, Murakami Hiroshi, Matsui Jun, Tanabe Jutaro, Matsuki Kota, Yamashita Maki, Suda Toshihiro
Ｊｏｕｒｎａｌ ｏｆ Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ ａｎｄ Ｔｈｒｏｍｂｏｓｉｓ 15 ( 1 ) 20 - 25 2008
-
Effects of combined PPARgamma and PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat.
Jutaro Tanabea, Naoki Tamasawaa, Maki Yamashitaa, Kota Matsukia, Hiroshi Murakamia, Jun Matsuia, Kazuhiro Sugimotob, Minoru Yasujimab, Toshihiro Sudaa
Diabetes, Obesity and Metabolism 10 ( 9 ) 772 - 779 2007.3
-
Nicorandil, ATP-sensitive K<SUP>+</SUP> channel opener, does not interfere with sulfonylureas and nateglinide in patients with type 2 diabetes
Matsuki Kota, Tanabe Jutaro, Yanagimachi Miyuki, Murakami Hiroshi, Tando Yusuke, Matsui Jun, Ogawa Yoshiji, Tamasawa Naoki, Suda Toshihiro
Shinzo 39 ( 8 ) 715 - 719 2007
-
Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
Tamasawa N, Matsui J, Murakami H, Tanabe J, Matsuki K, Ogawa Y, Ikeda Y, Takagi A, Suda T
Diabetes research and clinical practice 72 ( 1 ) 6 - 11 2006.4
-
Clinical characteristics of Japanese youth-onset type 2 diabetes with ketonuria.
Matsui J, Tamasawa N, Tanabe J, Kasai N, Murakami H, Matsuki K, Suda T
Diabetes research and clinical practice 70 ( 3 ) 235 - 8 2005.12
-
Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.
Yamato K, Tamasawa N, Murakami H, Matsui J, Tanabe J, Suda T, Yasujima M
Diabetes research and clinical practice 69 ( 2 ) 124 - 8 2005.8
-
LDL particle size and lipid composition are risk factors for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes.
Matsui J, Tamasawa N, Tanabe J, Kasai N, Murakami H, Yamato K, Guan J, Suda T
Diabetes research and clinical practice 66 ( 3 ) 229 - 36 2004.12
-
Effects of Fluvastatin in Type 2 Diabetic Patients with Hyperlipidemia : Reduction in Cholesterol Oxidation Products and VCAM-1
GUAN Jing-Zhi, MURAKAMI Hiroshi, YAMATO Kazumi, TANABE Jutaro, MATSUI Jun, TAMASAWA Naoki, SUDA Toshihiro
Journal of atherosclerosis and thrombosis 11 ( 2 ) 56 - 61 2004.4
-
EFFECT OF FENOFIBRATE ON LIPID LEVELS OF TYPE 2 DIABETIC PATIENTS WITH DYSLIPIDEMIA
村上 宏, 玉澤 直樹, 大和 一美, 田辺 壽太郎, 葛西 伸彦, 松井 淳, 管 静芝, 小川 吉司, 須田 俊宏
弘前医学 55 ( 3 ) 101 - 107 2004.3